| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Janssen |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Tempus |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Astellas Medivation |
| Recipient: You |
| Company: Dendreon |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Sanofi |
| Recipient: You |
| Company: Vividion |
| Recipient: You |
| Company: Calithera |
| Recipient: You |
| Company: Caris Life Sciences |
| Recipient: You |
| Company: Sorrento Therapeutics |
| Recipient: You |
| Company: AVEO |
| Recipient: You |
| Company: Seattle Genetics |
| Recipient: You |
| Company: Telix |
| Recipient: You |
| Company: Eli Lilly |
| Recipient: You |
| Company: Blue Earth Diagnostics |
| Recipient: You |
| Company: Ambrx |
| Recipient: You |
| Company: Sumitomo Pharma Oncology |
| Recipient: You |
| Company: Esiai |
| Recipient: You |
| Company: NeoMorph |
| Recipient: You |
| Company: Arcus Biosciences |
| Recipient: You |
| Company: Daiichi Sankyo |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: Bristol Myers Squibb |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Myovant |
| Recipient: You |
| Company: Precede Bio |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Tempus |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Exelixis |
| Recipient: Your Institution |
| Company: Bristol Myers Squibb |
| Recipient: Your Institution |
| Company: Oncternal Therapeutics |
| Recipient: Your Institution |
| Company: Artera |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|